Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Evaluate Safety of the ExAblate Model 2100 Type 1.1 System (ExAblate 2100/2000 UF V2 System) in the Treatment of Symptomatic Uterine Fibroids

NCT01285960 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT01285960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01285960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Evaluate Safety of the ExAblate Model 2100 Type 1.1 System (ExAblate 2100/2000 UF V2 System) in the Treatment of Symptomatic Uterine Fibroids
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2016
Enrollment
108 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids